Workflow
飞凯材料(300398) - 2022 Q3 - 季度财报(更正)
PhiChemPhiChem(SZ:300398)2024-05-14 11:47

Financial Performance - The company's operating revenue for Q3 2022 was ¥589,886,582.33, a decrease of 13.65% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2022 was ¥69,534,108.75, down 31.44% year-on-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥73,053,770.87, a decrease of 9.57% compared to the previous year[6]. - The basic earnings per share for Q3 2022 was ¥0.13, a decline of 35.00% from the same period last year[6]. - Total revenue for Q3 2022 reached ¥2,225,545,294.01, an increase of 18% compared to ¥1,885,656,486.92 in Q3 2021[28]. - Operating profit for the period was ¥373,464,713.77, up from ¥329,430,498.14 in the same period last year, reflecting a growth of approximately 13%[29]. - Net profit attributable to shareholders was ¥320,964,773.88, compared to ¥269,443,684.22 in Q3 2021, marking a year-over-year increase of about 19%[29]. - The total comprehensive income attributable to the parent company reached CNY 339,835,332.17, an increase from CNY 291,406,923.72 in the previous period, reflecting a growth of approximately 16.6%[30]. - Basic earnings per share increased to CNY 0.62 from CNY 0.53, representing a growth of 17%[30]. Assets and Liabilities - Total assets at the end of Q3 2022 reached ¥6,335,156,039.67, an increase of 8.12% compared to the end of the previous year[6]. - The total liabilities amounted to ¥2,655,745,288.57, slightly up from ¥2,611,915,930.79, indicating a marginal increase of about 2%[27]. - Current assets totaled ¥3,386,487,124.04, an increase of 13% from ¥2,994,855,061.36 in the previous year[26]. - The company's total assets as of September 30, 2022, included cash and cash equivalents, trading financial assets, and accounts receivable, reflecting a robust liquidity position[23]. Cash Flow - The cash flow from operating activities for the year-to-date period was ¥312,087,262.32, up 9.54% compared to the same period last year[6]. - Cash received from operating activities increased by 522.37% to ¥136,282,844.77 due to an increase in receivables[14]. - Cash received from financing activities increased by 600.13% to ¥105,019,999.00 as the company added new financing lease borrowings during the reporting period[14]. - Net cash flow from operating activities was CNY 312,087,262.32, compared to CNY 284,916,900.00 in the previous period, indicating an increase of about 9.5%[32]. - Cash inflow from operating activities totaled CNY 2,694,490,970.41, up from CNY 2,135,964,188.21, marking a rise of approximately 26%[31]. - The net cash flow from financing activities was CNY 186,286,577.26, a significant improvement compared to a net outflow of CNY 122,937,253.53 in the previous period[33]. - The ending balance of cash and cash equivalents increased to CNY 1,058,845,707.52 from CNY 944,137,163.65, reflecting a growth of approximately 12.1%[33]. Investments and Expenses - Investment income decreased by 81.39% to ¥9,900,253.19 due to a reduction in cash received from the sale of trading financial assets compared to the previous year[13]. - Research and development expenses for the quarter were ¥151,961,188.36, up from ¥134,375,118.09, showing an increase of about 13%[28]. - Financial expenses decreased by 48.57% to ¥27,817,098.12 primarily due to reduced interest expenses after debt-to-equity swaps and increased foreign exchange gains[13]. - Other income decreased by 35.89% to ¥12,215,212.04 as government subsidies recognized during the reporting period were lower than the previous year[13]. - Cash outflow from investing activities was CNY 757,999,458.03, down from CNY 1,365,332,773.66, showing a decrease of about 44.5%[32]. - The company’s total cash inflow from investment activities was CNY 491,462,672.34, down from CNY 861,538,196.71, representing a decrease of approximately 43%[32]. Shareholder Information - The number of common shareholders at the end of the reporting period was 44,107[16]. - The company plans to grant 6,353,000 shares of restricted stock to 180 incentive targets at a price of ¥10.71 per share as part of its 2022 restricted stock incentive plan[22]. - The total number of restricted shares subject to lock-up at the end of the period was 3,669,075 shares, with 2,080,800 shares released during the period[20]. - The company completed the repurchase and cancellation of 60,760 shares of restricted stock from four former employees who left the company[22]. - The company’s total number of restricted shares at the beginning of the period was 5,546,755 shares, with a total of 2,080,800 shares released during the period[20]. Regulatory Compliance - The company is undergoing rectification measures as per the regulatory requirements from the China Securities Regulatory Commission[6].